Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes...
Codon Optimization Isn’t Equal: Benchmarking Gene Design for Antibody Expression
Nature Biotechnology, Published online: 19 May 2026; doi:10.1038/s41587-026-03116-1 RNovA is an open-search de novo peptide sequencing model.
The Maryland Prescription Drug Affordability Board agreed to set an upper payment limit for the Ozempic diabetes treatment, marking the second time that the state panel...
The latest Ebola outbreak in the Democratic Republic of the Congo, which was only confirmed to be underway at the end of last week, is already...
More than one million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, optic nerves, and spine. MS is...
The Trump administration is opening the floodgates for Affordable Care Act exchanges to feature plans that offer bare-bones coverage and fewer protections, but which have lower...
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
BioSpace examines how the FDA approval of Eli Lilly’s oral obesity drug Foundayo has ignited a key race with Novo Nordisk.
FDA's unreleased Covid vaccine deaths report is published by lawmaker